Cargando…

EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR

Long noncoding RNAs play an essential role in bladder cancer progression. The role of long noncoding RNA EGFR-AS1 in bladder cancer needs further study. We used clinical specimens to analyze the relationship between EGFR-AS1 and bladder cancer patients' characteristics. The functional experimen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Anbang, Jiang, Aimin, Gan, Xinxin, Wang, Zheng, Huang, Jinming, Dong, Kai, Liu, Bing, Wang, Linhui, Chen, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781701/ https://www.ncbi.nlm.nih.gov/pubmed/33426060 http://dx.doi.org/10.1155/2020/6665974

Ejemplares similares

Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer
por: Wang, Anbang, et al.
Publicado: (2019)

Cell Adhesion-Related Molecules Play a Key Role in Renal Cancer Progression by Multinetwork Analysis
por: Wang, Anbang, et al.
Publicado: (2019)

Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway
por: Li, Piao, et al.
Publicado: (2022)

Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression
por: Huang, Zhixin, et al.
Publicado: (2019)

Morphine promotes microglial activation by upregulating the EGFR/ERK signaling pathway
por: Yang, Yaqiong, et al.
Publicado: (2021)

Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
por: Wei, Zhigang, et al.
Publicado: (2017)

SPC24 promotes osteosarcoma progression by increasing EGFR/MAPK signaling
por: Sheng, Jun, et al.
Publicado: (2017)

Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis
por: Jiang, Aimin, et al.
Publicado: (2022)

ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway
por: Xu, Jinming, et al.
Publicado: (2023)

JMJD8 Promotes Malignant Progression of Lung Cancer by Maintaining EGFR Stability and EGFR/PI3K/AKT Pathway Activation
por: Zhang, Bo, et al.
Publicado: (2021)

RHBDD1 upregulates EGFR via the AP-1 pathway in colorectal cancer
por: Miao, Fei, et al.
Publicado: (2017)

Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2021)

Upregulated SPAG6 promotes acute myeloid leukemia progression through MYO1D that regulates the EGFR family expression
por: Mu, Jiao, et al.
Publicado: (2022)

Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth
por: Yao, Nan, et al.
Publicado: (2020)

Pyk2 promotes tumor progression in renal cell carcinoma
por: Zhao, Tangliang, et al.
Publicado: (2018)

TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target
por: Yu, Jiao-jiao, et al.
Publicado: (2020)

S645C Point Mutation Suppresses Degradation of EGFR to Promote Progression of Glioblastoma
por: Huang, Wenda, et al.
Publicado: (2022)

DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma
por: Zhao, Tangliang, et al.
Publicado: (2019)

Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
por: Chen, Hongjin, et al.
Publicado: (2021)

PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy
por: Fang, Wenfeng, et al.
Publicado: (2020)

Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations
por: Yang, Yudie, et al.
Publicado: (2022)

METTL1‐m(7)G‐EGFR/EFEMP1 axis promotes the bladder cancer development
por: Ying, Xiaoling, et al.
Publicado: (2021)

P3H4 Promotes Malignant Progression of Lung Adenocarcinoma via Interaction with EGFR
por: Fang, Chen, et al.
Publicado: (2022)

Establishment of prognostic nomograms for predicting the progression free survival of EGFR‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs
por: Du, Xinyang, et al.
Publicado: (2022)

LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT
por: Xie, Qiubo, et al.
Publicado: (2020)

Methyltransferase‐like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1
por: Liu, Tao, et al.
Publicado: (2021)

Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma
por: Ma, Xiaoyan, et al.
Publicado: (2016)

A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy
por: Gan, Jiadi, et al.
Publicado: (2021)

Long non-coding RNA EGFR-AS1 sponges micorRNA-381 to upregulate ROCK2 in bladder cancer
por: Yuan, Shouxian, et al.
Publicado: (2020)

EGFR-ERK induced activation of GRHL1 promotes cell cycle progression by up-regulating cell cycle related genes in lung cancer
por: He, Yiming, et al.
Publicado: (2021)

Phosphorylated STYK1 restrains the inhibitory role of EGFR in autophagy initiation and EGFR-TKIs sensitivity
por: Zhou, Cefan, et al.
Publicado: (2022)

KIF15 Promotes Progression of Castration Resistant Prostate Cancer by Activating EGFR Signaling Pathway
por: Gao, Lin, et al.
Publicado: (2021)

DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma
por: Bao, Yewei, et al.
Publicado: (2021)

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression
por: Pan, Zhenzhen, et al.
Publicado: (2022)

CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
por: Xu, Hanxiao, et al.
Publicado: (2016)

Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs
por: Zhang, Chengjuan, et al.
Publicado: (2017)

Upregulation of Bcl2 in NSCLC with acquired resistance to EGFR-TKI
por: Cheong, Hio Teng, et al.
Publicado: (2018)

EGFR-induced phosphorylation of type Iγ phosphatidylinositol phosphate kinase promotes pancreatic cancer progression
por: Chen, Chunhua, et al.
Publicado: (2017)

Research progress on criteria for discontinuation of EGFR inhibitor therapy
por: Zhuang, Hong-qing, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4faad2fj2bh4f9j2jd5bsep3f3